• KOL
    • Juvenile Idiopathic Arthritis
    • Taunton R Southwood
    • Taunton R Southwood: Influence Statistics

      Taunton R Southwood

      Taunton R Southwood

      Show email address

      Institute of Child Health, University of Birmingham, B15 2TT, Birmingham, UK | Institute of Child Health, University of Birmingham and Birmingham Children's Hospital, ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Taunton R Southwood:Expert Impact

      Concepts for whichTaunton R Southwoodhas direct influence:Juvenile idiopathic arthritis,Young people,Juvenile chronic arthritis,British society,Occupational therapy,Clinically inactive disease,Idiopathic arthritis,Juvenile idiopathic.

      Taunton R Southwood:KOL impact

      Concepts related to the work of other authors for whichfor which Taunton R Southwood has influence:Juvenile idiopathic arthritis,Young people,Patients jia,Rheumatic diseases,Inactive disease,Temporomandibular joint,Atrial fibrillation.

      KOL Resume for Taunton R Southwood

      Year
      2020

      Institute of Child Health, University of Birmingham, B15 2TT, Birmingham, UK

      2019

      Institute of Child Health, University of Birmingham & Birmingham Children’s Hospital, Birmingham

      2018

      School of Immunity and Infection, Birmingham University, Birmingham

      2016

      Department of Paediatric Rheumatology, Institute of Child Health, Birmingham Children’s Hospital – NHS Trust and University of Birmingham, Birmingham,

      2015

      Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Sciences Centre and Institute of Child Health, University of Birmingham and Birmingham Children's Hospital, Birmingham, UK

      Department of Paediatric Rheumatology, Institute of Child Health, Birmingham Children’s Hospital – NHS Trust and University of Birmingham, Birmingham and

      2014

      Institute of Child Health, Birmingham Children’s Hospital, Birmingham, UK

      2013

      Department of Paediatric Rheumatology, Birmingham Children's Hospital, Birmingham, UK

      School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom;

      2011

      Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK

      2010

      Department of Paediatric Rheumatology, Institute of Child Health, Birmingham Children's Hospital – NHS Foundation Trust and University of Birmingham, Birmingham, 2Musculoskeletal Research Group, Institute Cellular Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, 3Rheumatology Department, Royal Hospital for Sick Children, Yorkhill, Glasgow, 4Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, 5Institute of Child Health, Birmingham Children's Hospital – NHS Foundation Trust and University of Birmingham, Birmingham, 6Institute of Child Health, University College London and Great Ormond Street Hospital, London, 7Department of Rheumatology, Queen Alexandra Hospital, Portsmouth and 8Nottingham Children's and Young Peoples Rheumatology Service, Nottingham Children's Hospital, Nottingham, UK

      2006

      Department of Rheumatology, Birmingham Children’s Hospital, Birmingham, UK

      2005

      Derriford Hospital, Plymouth, UK

      2004

      Institute of Child Health, Division of Reproductive and Child Health, University of Birmingham, Birmingham B15 2TT, UK

      2003

      Department of Rheumatology, Division of Immunity and Infection, University of Birmingham, Birmingham, UK

      2002

      Department of Rheumatology, University of Birmingham, Birmingham, UK

      Institute of Child Health, University of Birmingham, Birmingham Children's Hospital – NHS Trust, Steelhouse Lane, Birmingham, B4 6NH, U.K.

      2000

      University of Birmingham Medical School, Birmingham, UK

      1998

      Birmingham Children's Hospital, Birmingham B16 8ET

      1997

      Department of Rheumatology, University of Birmingham.

      1996

      Paediatric Rheumatology Department, Birmingham Children's Hospital-NHS Trust, The General HospitalSteelhouse Lane, Birmingham B4 6NH

      Department of Rheumatology, University of BirminghamEdgbaston, Birmingham B15 2TT

      1995

      Department of Rheumatology, University of Birmingham, Edgbaston, UK.

      Childhood Arthritis Unit, University of BirminghamBirmingham B15 2TJ

      1993

      Department of Rheumatology, University of Birmingham, United Kingdom.

      1991

      Department of Rheumatology, Medical School, University of Birmingham, United Kingdom.

      1990

      Renal Unit, Adelaide Chidren's Hospital, 5006, North Adelaide, S.A., Australia

      Department of Paediatrics, University of British Columbia, Vancouver, Canada.

      1989

      Division of Rheumatology, Department of Paediatrics and the Department of Radiology, University of British Columbia, Vancouver, British Columbia, and the University of Manitoba, Winnipeg, Manitoba, Canada

      1988

      Divisions of Rheumatology, Immunology, and General Pediatrics, Departments of Pediatrics and Pathology, University of British Columbia, Vancouver, British Columbia, Canada

      1987

      Adelaide Children's Hospital, North Terrace, North Adelaide, SA, 5006

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Taunton R Southwood is among the top experts in the world.
      Concept World rank
      jia mild severe #1
      jia rtx #1
      jia 303 #1
      classification conundrum #1
      gait patterns clinical #1
      gap scale transitional #1
      jia observed relationships #1
      juvenile childhood arthritis #1
      evaluation jia #1
      improved anabolic state #1
      predictable outcomes responses #1
      adolescent jaqq #1
      immunoglobulin uveitis anterior #1
      transitional adolescent rheumatology #1
      childhood arthritis consideration #1
      newly diagnosed uveitis #1
      308 86 adolescents #1
      systemic arthritis #1
      vitamin mineral mixtures #1
      conclusion verifying #1
      hrqol jaqq #1
      anterior jca #1
      careers advice adolescents #1
      gap rheumatology #1
      programme transitional #1
      359 families #1
      prevocational adolescents #1
      study prevocational #1
      juvenile child continuity #1
      increased transfer preparation #1
      17yrold cohort #1
      vocational workload #1
      rare vasculitides #1
      303 parents guardians #1
      documentation provisions #1
      underestimation health domain #1
      prevocational #1
      swollen fingers #1
      individual components programme #1
      participate 308 #1
      confidence perceived role #1
      phase plasma calcium #1
      parents cronbachs alphas #1
      jia majority #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Taunton R Southwood

      KOL-Index: 11039

      BACKGROUND: To develop a scale to assess satisfaction with transitional health care among adolescents with a chronic illness and their parents.

      METHODS: The 'Mind the Gap' scale was developed using evidence from a previous needs assessment, in three stages: (1) definition of the construct; (2) design of the scale items, response options and instructions; (3) full administration of the scale, item analysis and dimensionality analysis. The scale was administered to 308 adolescents with ...

      Known for Transitional Health | Adolescents Parents | Chronic Illness | Idiopathic Arthritis | Gap Scale
      KOL-Index: 10981

      OBJECTIVE: Since 2004, juvenile idiopathic arthritis (JIA) patients treated with etanercept and/or MTX have been monitored in the British Society for Paediatric and Adolescent Rheumatology Biologics and New Drug Register. Here, we report the duration of etanercept use for the first 5 years of the register and reasons for discontinuation.

      METHODS: Disease subtype and activity, comorbidity, treatment efficacy and safety data were recorded. Etanercept discontinuation was defined as stopping ...

      Known for Etanercept Treatment | Idiopathic Arthritis | Reasons Discontinuation | 5 Years | Male Receptors
      KOL-Index: 10917

      OBJECTIVE: To describe the health-related quality of life (HRQOL) of adolescents with juvenile idiopathic arthritis (JIA), and to examine the usefulness of the Juvenile Arthritis Quality of Life Questionnaire (JAQQ) in a UK context. It was hypothesized that HRQOL would decrease with worsening disease and disability.

      METHODS: Patients with JIA ages 11, 14, and 17 years were recruited from 10 major rheumatology centers. HRQOL was measured using the JAQQ. Other data were core outcome ...

      Known for Life Hrqol | Adolescents Jia | Health‐related Quality | Juvenile Idiopathic | Demographic Characteristics
      KOL-Index: 10664

      BACKGROUND: To examine the quality of transitional health care from the perspectives of young people with juvenile idiopathic arthritis (JIA) and their parents.

      METHODS: Adolescents with JIA and their parents were recruited from 10 major UK rheumatology centres. Satisfaction with health-care delivery was measured prior to, and 12 months after, the implementation of a structured and co-ordinated programme of transitional care using self-completed questionnaires designed for this ...

      Known for Young People | Adolescent Rheumatology | Jia Parents | Patient Female Humans | Quality Health
      KOL-Index: 10499

      OBJECTIVE: To examine agreement about physical health, functional ability, and health-related quality of life (HRQOL) between adolescents with juvenile idiopathic arthritis (JIA) and their parents.

      METHODS: The study group comprised 303 adolescent-parent dyads who completed individual questionnaires, including the Childhood Health Assessment Questionnaire with visual analog scales for pain and general well-being, and the Juvenile Arthritis Quality of Life Questionnaire. Agreement was ...

      Known for Juvenile Idiopathic Arthritis | Adolescents Parents | Functional Ability | Life Hrqol | Physical Health
      KOL-Index: 10320

      OBJECTIVE: Juvenile idiopathic arthritis (JIA) can persist through adolescence and adulthood, resulting in significant disability. The use of low-dose oral methotrexate (MTX) for persistent polyarthritis has been shown to be effective by the USA/USSR collaborative study group. However, 2 of the most disabling subgroups of JIA, systemic and extended oligoarthritis, were underrepresented in that study. The present study was therefore conducted to investigate the efficacy of MTX in these 2 ...

      Known for Systemic Arthritis | Mtx Treatment | Extended Oligoarticular | Humans Immunoglobulin | International League
      KOL-Index: 10141

      OBJECTIVE: The association between anti-tumor necrosis factor therapy and increased rates of infection is widely documented in adults with rheumatoid arthritis. Findings in children with juvenile idiopathic arthritis (JIA) have been less well documented. The aims of this analysis were to compare the rates of medically significant infections (MSIs) in children with JIA treated with etanercept (ETN) versus methotrexate (MTX) and to compare the rates between combination therapy with ETN ...

      Known for British Society | Infections Patients | Agents Arthritis | Etanercept Cohort | Children Juvenile
      KOL-Index: 10122

      OBJECTIVE: To identify the ideal programme of transitional care for adolescents with juvenile idiopathic arthritis (JIA) as perceived by users and providers, and to examine the feasibility of achieving this within a UK National Health Service context.

      METHODS: A modified two-stage Delphi study was undertaken with rheumatology health professionals, young people with JIA (aged 12-25 yr) and their parents. Participants were presented with statements about transitional care and asked to rate ...

      Known for Juvenile Idiopathic Arthritis | Adolescents Jia | Patient Delivery | Young People | Delphi Study
      KOL-Index: 9973

      BACKGROUND: The frequency and ethnic variation of Henoch-Schönlein purpura, Kawasaki disease, and rarer vasculitides during childhood are not well characterised. Our aim was to ascertain the incidence and ethnic distribution of these conditions in children resident in a region of the UK with a diverse ethnic mix.

      METHODS: 1.1 million children younger than age 17 years live in the West Midlands. Between Sept 1, 1996, and Aug 31, 1999, we surveyed this population with monthly ...

      Known for Kawasaki Disease | Rare Vasculitides | Henochschönlein Purpura | Children Vasculitis | Incidence Infant
      KOL-Index: 9548

      OBJECTIVE: The objectives of this study were to describe patients starting first-line biologics for JIA, to describe characteristics over time among patients starting etanercept, and to describe patterns of second biologic prescribing.

      METHODS: The British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study, and the Biologics for Children with Rheumatic Diseases study are ongoing prospective observational cohorts, collecting data on patients starting biologic ...

      Known for Jia Patients | Humanized Arthritis | Rheumatic Diseases | Choice Biologic | British Society
      KOL-Index: 8927

      OBJECTIVES: To determine the perceived education and training needs of health professionals involved in transitional care for adolescents with juvenile idiopathic arthritis (JIA).

      METHODS: Two distinct questionnaires to identify transitional issues in JIA were distributed to key health professionals (n = 908) and clinical personnel involved in the implementation of a transitional care programme (n = 22).

      RESULTS: The first survey was completed by 263 professionals. Education needs were ...

      Known for Health Professionals | Transitional Adolescents | Lack Training | Unmet Education | Teaching Materials
      KOL-Index: 8684

      OBJECTIVE: There is an extensive evidence base for the need of transitional care, but a paucity of robust outcome data. The aim of the study was to determine whether the quality of life of adolescents with juvenile idiopathic arthritis (JIA) could be improved by a co-ordinated, evidence-based programme of transitional care.

      METHODS: Adolescents with JIA aged 11, 14 and 17 yrs and their parents were recruited from 10 rheumatology centres in the UK. Data were collected at baseline, 6 and ...

      Known for Juvenile Idiopathic Arthritis | Life Adolescents | Patient Delivery | 12 Months | Adolescent Health
      KOL-Index: 8514

      OBJECTIVES: The objectives of this study were to investigate change in disease activity, and explore factors associated with response, in children with JIA over the initial year of etanercept treatment.

      METHODS: This analysis included children with JIA starting etanercept in the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Response was assessed using change in juvenile arthritis disease activity score-71 (JADAS-71), an excellent response (ACR Pedi ...

      Known for 1 Year | Young People | Juvenile Idiopathic Arthritis | British Society | Children Jia

      Key People For Juvenile Idiopathic Arthritis

      Top KOLs in the world
      #1
      Ross Edward Petty
      juvenile idiopathic arthritis systemic lupus erythematosus rubella virus
      #2
      Anne Marie Prieur
      juvenile chronic arthritis body composition growth hormone
      #3
      Taunton R Southwood
      juvenile idiopathic arthritis young people united kingdom
      #4
      David N Glass
      juvenile rheumatoid arthritis gene expression calcium supplementation
      #5
      Alberto Martini
      juvenile idiopathic arthritis inactive disease macrophage activation syndrome
      #6
      Prudence Joan Manners
      juvenile arthritis growing pains severe hemophilia

      Institute of Child Health, University of Birmingham, B15 2TT, Birmingham, UK | Institute of Child Health, University of Birmingham and Birmingham Children's Hospital, Birmingham, UK | Institute of Child Health, University of Birmingham & Birmingham C

    Download on the App StoreGet it on Google Play

    Copyright © 2023 KOL - Key Opinion Leaders, LLC.

    KOL does not provide medical advice, diagnosis or treatment.